Annual Shareholders Equity:
$1.03B+$571.35M(+123.28%)Summary
- As of today, RXRX annual stockholders equity is $1.03 billion, with the most recent change of +$571.35 million (+123.28%) on December 31, 2024.
- During the last 3 years, RXRX annual shareholders equity has risen by +$491.84 million (+90.59%).
- RXRX annual shareholders equity is now at all-time high.
Performance
RXRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
$919.15M-$14.80M(-1.58%)Summary
- As of today, RXRX quarterly stockholders equity is $919.15 million, with the most recent change of -$14.80 million (-1.58%) on June 30, 2025.
- Over the past year, RXRX quarterly shareholders equity has increased by +$334.70 million (+57.27%).
- RXRX quarterly shareholders equity is now -11.17% below its all-time high of $1.03 billion, reached on December 31, 2024.
Performance
RXRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RXRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +123.3% | +57.3% |
| 3Y3 Years | +90.6% | +110.0% |
| 5Y5 Years | +1246.6% | - |
RXRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +123.3% | -11.2% | +136.9% |
| 5Y | 5-Year | at high | +1246.6% | -11.2% | +545.6% |
| All-Time | All-Time | at high | +1246.6% | -11.2% | +545.6% |
RXRX Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $919.15M(-1.6%) |
| Mar 2025 | - | $933.95M(-9.7%) |
| Dec 2024 | $1.03B(+123.3%) | $1.03B(+97.3%) |
| Sep 2024 | - | $524.56M(-10.2%) |
| Jun 2024 | - | $584.45M(+45.7%) |
| Mar 2024 | - | $401.15M(-13.4%) |
| Dec 2023 | $463.44M(-4.6%) | $463.44M(+5.8%) |
| Sep 2023 | - | $437.97M(-6.6%) |
| Jun 2023 | - | $468.96M(+9.0%) |
| Mar 2023 | - | $430.18M(-11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $485.81M(-10.5%) | $485.81M(+25.2%) |
| Sep 2022 | - | $388.03M(-11.3%) |
| Jun 2022 | - | $437.58M(-11.3%) |
| Mar 2022 | - | $493.57M(-9.1%) |
| Dec 2021 | $542.94M(+124.3%) | $542.94M(-9.4%) |
| Sep 2021 | - | $599.03M(-6.8%) |
| Jun 2021 | - | $642.71M(+198.5%) |
| Mar 2021 | - | $215.28M(+204.4%) |
| Dec 2020 | $242.02M(+215.0%) | - |
| Dec 2020 | - | -$206.29M |
| Dec 2019 | $76.84M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual stockholders equity?
The current annual shareholders equity of RXRX is $1.03B
What is the all-time high annual shareholders equity for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual stockholders equity is $1.03B
What is Recursion Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
Over the past year, RXRX annual stockholders equity has changed by +$571.35M (+123.28%)
What is Recursion Pharmaceuticals, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of RXRX is $919.15M
What is the all-time high quarterly shareholders equity for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $1.03B
What is Recursion Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
Over the past year, RXRX quarterly stockholders equity has changed by +$334.70M (+57.27%)